Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s): NRIFF|NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $3.00 | Change: $0.00 | % Change: 0.00%
Volume: 3,343 | Day High/Low: 3.00/3.00 | 52 Week High/Low: 5.73/1.30

View modes: 
5 stars

Reps confirm launch and reveal some promising strategy?

From Café Pharma: a confirmation of launch and some pricing strategy is revealed in the following excerpt posting: "When was the last time a pharmaceutical company improved a drug and lowered the...read more
0 stars

new to stocks.. and wondering..

hey guys I am new to stocks and am really confused.. with this company. how come this company is loosing its share value even after getting the 2% approved by FDA? and I am guessing that when they do...read more
3 stars

Do not panic!!

Seriously about 16k shares traded!! This represents 0.18% of the outstanding shares... Please stop questioning everything...because some idiots decided to sell following the approval of Pennsaid 2!!...read more
0 stars

RE:RE:RE:RE:Will gap get filled at $2.25?

Some things are a lot harder to crack  than others.  rate and reply
0 stars

RE:RE:RE:Will gap get filled at $2.25?

The are few sellers as lite volumes demonstrate. Most of the sells are in sub 400 lots.......these are the  retail sheep .  I see more of the crazies here every day........like applying TA to a stock...read more
0 stars

RE:RE:Will gap get filled at $2.25?

Great summary C99. As you can see, reading it back, there are nothing but questions. No answers. And that's why the share price is dropping.  Curious to know if these guys sold any of the shares they...read more
0 stars

$2.66 rtq

nm  rate and reply
0 stars

RE:RE:Will gap get filled at $2.25?

My mistake.  Gap is on the weekly chart (see below), and the 50dma should have been referred to as the 50 wma. Just took out $2.75 and looking to go lower now.  Still looks to me like the $2.25 is...read more
5 stars

RE:Will gap get filled at $2.25?

First off $2.76 is holding for now but I agree that it is looking a little shaky here right now. We must be using different charts because I see further support around the $2.60 level as that is where...read more
0 stars

would anyone mind posting level II?

want to see if there is any support left below $2.75 thanks  rate and reply
5 stars

RE:Will gap get filled at $2.25?

It's gone back to sleep because, despite the pumping efforts of TheRock07 and other brilliant mindreaders, the general market has no idea wether Pennsaid 2% will be sold in the US and by whom. The...read more
3 stars

Will gap get filled at $2.25?

it's looking like if the current $2.75 range does not hold, that it will be a waterfall down to the $2.25 area, exactly at the confluence of the 50 day moving average, a significant gap that was...read more
2.5 stars

RE:Patents

There is substantial current and future value here that is well above the current market cao of $22 million of which about $14.5 million is cash. Paladin is our mentor, we have $125 million US coming...read more
1 star

Patents

Nuvo Pennsaid until 2028 http://www.prnewswire.com/news-releases/nuvo-research-announces-notice-of-intention-to-grant-a-european-patent-for-pennsaid-2-206733721.html Zalicus Exalgo until 2014 http...read more
5 stars

RE:RE:Who's Pumping?

Hang around longer and that will happen to you too.  rate and reply
1 star

RE:Who's Pumping?

Are you bitter or just nuts? Or both?  rate and reply
5 stars

Who's Pumping?

Who is pumping this stock? 14 mil in the bank and 8 mil debt???? Out landish projections? BIG bonuses coming to the Execs? Lawsuit 50-50 chance? Dump the BofD and we might get somewhere? Everytime NRI...read more
3 stars

RE:Strong buy

Im getting picky with what I read. Anyone joining SI days ago who claiims he's in the stock for 5 years gos on my ignore list.  rate and reply
1 star

RE:Strong buy

In July, 2013, the company sold the exclusive rights to market and sell Synera in the United States for its current indication to Galen U.S. Inc. for $4.5-million (U.S.) received on closing, royalties...read more
3 stars

RE:Strong buy

Who in there right mind would buy this stock just look at there chart  / Well if making money is not a factor then go a head and buy. IMHO  rate and reply